Westside Investment Management, Inc. - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 61 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Westside Investment Management, Inc. ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$7,480
-99.8%
5000.0%0.02%
+80.0%
Q3 2022$4,115,000
+48.3%
5000.0%0.01%
+66.7%
Q2 2022$2,775,0000.0%5000.0%0.01%0.0%
Q1 2022$2,775,000
-11.5%
5000.0%0.01%
-14.3%
Q4 2021$3,135,0000.0%5000.0%0.01%0.0%
Q3 2021$3,135,000
-4.9%
5000.0%0.01%
-12.5%
Q2 2021$3,295,000
-10.0%
5000.0%0.01%
-20.0%
Q1 2021$3,660,000
+26.9%
5000.0%0.01%
+25.0%
Q4 2020$2,885,000
-2.9%
5000.0%0.01%
+700.0%
Q3 2020$2,970,000
+15.3%
5000.0%0.00%
-50.0%
Q2 2020$2,575,000
-95.2%
500
-50.0%
0.00%
-94.6%
Q1 2020$54,120,0001,0000.04%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,739,255$22,544,0007.01%
Worth Venture Partners, LLC 685,026$5,638,0003.45%
NEA Management Company, LLC 3,952,957$32,533,0001.62%
Birchview Capital, LP 140,000$1,152,0000.81%
Rubric Capital Management LP 1,664,667$13,700,0000.69%
EAM Investors, LLC 380,691$3,133,0000.68%
GLOBEFLEX CAPITAL L P 368,520$3,033,0000.52%
X-Square Capital, LLC 92,283$759,0000.48%
EAM Global Investors LLC 211,759$1,743,0000.46%
J. Goldman & Co LP 656,161$5,400,0000.26%
View complete list of AVEO PHARMACEUTICALS INC shareholders